Detalhe da pesquisa
1.
Eribulin promotes proliferation of CD8+ T cells and potentiates T cell-mediated anti-tumor activity against triple-negative breast cancer cells.
Breast Cancer Res Treat
; 203(1): 57-71, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733186
2.
Emerging measurements for tumor-infiltrating lymphocytes in breast cancer.
Jpn J Clin Oncol
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521965
3.
Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer.
Ann Surg
; 278(4): 587-597, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318852
4.
High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer.
Breast Cancer Res Treat
; 193(1): 49-63, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249172
5.
Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.
Breast Cancer Res Treat
; 195(1): 17-31, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35793004
6.
Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer.
Breast Cancer Res Treat
; 192(1): 19-32, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018543
7.
Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.
Breast Cancer Res Treat
; 194(2): 231-241, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639264
8.
High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
Ann Surg Oncol
; 28(12): 7356-7365, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966140
9.
Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
J Mammary Gland Biol Neoplasia
; 25(1): 27-36, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109311
10.
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
Ann Surg Oncol
; 27(11): 4475-4485, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436191
11.
MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer.
Int J Mol Sci
; 21(21)2020 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33143224
12.
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Int J Mol Sci
; 21(18)2020 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933189
13.
CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.
Int J Mol Sci
; 21(18)2020 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971948
14.
G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer.
Int J Mol Sci
; 21(8)2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32331421
15.
Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer.
Int J Mol Sci
; 21(13)2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32629782
16.
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Int J Mol Sci
; 21(16)2020 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796516
17.
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Int J Mol Sci
; 21(9)2020 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357442
18.
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.
Int J Mol Sci
; 21(9)2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32370060
19.
Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
Ann Surg Oncol
; 26(2): 593-603, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30483976
20.
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
Int J Mol Sci
; 20(11)2019 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151151